Einloggen
Einloggen
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrieren
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.

(300601)
  Bericht
Schlusskurs Shenzhen Stock Exchange  -  26.09.2022
28.44 CNY   -4.88%
29.08.Chinas CanSinoBIO Umsatz sinkt im ersten Halbjahr aufgrund schwächerer Nachfrage nach COVID-Spritzen
MR
22.08.Shenzhen Kangtai Biological Products Co., Ltd. : erhält Kaufen-Rating von UBS
MM
18.08.Shenzhen Kangtai Biological Products Co., Ltd. (SZSE:300601) kündigt einen Aktienrückkauf im Wert von CNY 200 Millionen an.
CI
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenFonds 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
29.08.China's CanSinoBIO H1 revenue drops on weaker COVID shot demand
18.08.Shenzhen Kangtai Biological Products Co., Ltd. announces an Equity Buyback for CNY 200 ..
18.08.Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Half Ye..
18.08.Shenzhen Kangtai Biological Products Co., Ltd. authorizes a Buyback Plan.
26.07.Kangtai Biological Sees Up to 70% Profit Slump in H1
27.05.Shenzhen Kangtai Biological Products Co., Ltd. Announces Final Cash Dividend for the Ye..
23.05.Shenzhen Kangtai Biological Products Co., Ltd. Approves Final Cash Dividend for the Yea..
29.04.Kangtai Biological's 2021 Profit Surges 86% on Robust Sales
28.04.Shenzhen Kangtai Biological Products Co., Ltd. Announces Final Cash Dividend Proposal f..
27.04.Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the First Q..
15.04.Kangtai Biological's Q1 Profit Seen Soaring 11-Fold on Strong Sales
13.04.Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Full Ye..
21.03.Shenzhen Kangtai Biological Products Co., Ltd Signs Framework Agreement with Phil.Pharm..
2021China accelerating research into COVID-19 shots targeting Omicron - state media
2021Shenzhen Kangtai Biological Products Co., Ltd. Announces Export of Kangtai Adenovirus V..
2021AstraZeneca's Chinese Distributor Sends First Vaccine Shipment To Indonesia
2021China's BioKangtai begins first shipment of AstraZeneca's COVID-19 shot
2021National Agency of Drug and Food Control Grants the Emergency Use Authorization for Cov..
2021Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Mo..
2021Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Mo..
2021Shenzhen Kangtai Biological Products Co., Ltd. Announces 2021 Interim Distribution Plan..
2021Shenzhen Kangtai Biological Products Co., Ltd. Approves Interim Cash Dividend for the F..
2021Shenzhen Kangtai Biological Products Co., Ltd. Announces Recombinant COVID-19 Vaccine (..
2021Shenzhen Kangtai Biological Products Co., Ltd. Proposes Cash Dividend for the First Hal..
2021Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Half Ye..
2021Shenzhen Kangtai Biological Products Co., Ltd. Announces Philippine Food and Drug Admin..
2021Shenzhen Kangtai Biological Products : Kangtai Biol..
2021Phase III Clinical Fieldwork of the Inactivated COVID-19 Vaccine (Vero Cells) Independe..
2021Shenzhen Kangtai Biological Products : Kangtai Biol..
2021China's Kangtai Biological, partners agree to run Phase III trial in Chile - Xinhua
2021Shenzhen Kangtai Biological Products Co., Ltd. Not to Pay Dividend for the Year 2020
2021Shenzhen Kangtai Biological Products : China Approv..
2021Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the First Q..
2021Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Full Ye..
2021YTB Healthcare Sdn Bhd Enters into Phase III Clinical and Product Procurement Agreement..
2021Market Chatter: Kangtai Biological to Produce 400 Million AstraZeneca COV..
2021AstraZeneca : China partner expects to be able to make 400 mln COVID-19 vacc..
2020Fosun Pharma to buy 100 million doses of BioNTech's COVID-19 vaccine for mainland China
2020Yong Tai Berhad Announces Heads of Agreement Between YTB and shenzen kangtai biological..
2020China's Rhodiola set to sell and test Russia's Sputnik-V vaccine
2020Shenzhen Kangtai Biological Products : AstraZeneca'..
2020Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Mo..
2020Shenzhen Kangtai Biological Products : China's Kang..
2020China's Kangtai gets approval for clinical trial of coronavirus vaccine candidate
2020Shenzhen Kangtai Biological Products Co., Ltd.(XSEC..
2020Shenzhen Kangtai Biological Products Co., Ltd. Announces Interim Distribution for 2020,..
2020AstraZeneca Sets Deal in China Market -- WSJ
2020AstraZeneca Strikes Deal to Produce Covid-19 Vaccine for China
2020AstraZeneca in first COVID-19 vaccine deal with Chinese company
2020AstraZeneca in first COVID-19 vaccine deal with Chinese company
2020Shenzhen Kangtai Biological Products : AstraZeneca ..
2020Shenzhen Kangtai Biological Products Co., Ltd. Announces Profit Distribution Proposal f..
2020Shenzhen Kangtai Biological Products Co., Ltd. Announces Cash Dividend for First Half o..
2020Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Half Ye..
2020Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Full Ye..
2020Shenzhen Kangtai Biological Products Co., Ltd. announced that it has received CNY 2.999..
2019Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Mo..
2019Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Half Ye..
2019Shenzhen Kangtai Biological Products Co., Ltd.(XSEC..
2019Shenzhen Kangtai Biological Products Co., Ltd. Approves Final Cash Dividend for the Yea..
2019Shenzhen Kangtai Biological Products Co., Ltd. announced that it expects to receive CNY..
2019Shenzhen Kangtai Biological Products Co., Ltd. Proposes Final Cash Dividend for the Yea..
2019Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the First Q..
2018Shenzhen Kangtai Biological Products Co., Ltd.(SZSE..
2018Shenzhen Kangtai Biological Products Co., Ltd.(SZSE..
2018Shenzhen Kangtai Biological Products Co., Ltd. Announces Cash Dividend for 2017, Payabl..
2018Shenzhen Kangtai Biological Products Co., Ltd. Approves Cash Dividend
2018Shenzhen Kangtai Biological Products Co., Ltd. Proposes Final Cash Dividend for the Yea..
2017Beijing Minhai Biotechnology Co., Ltd. announced that it has received CNY 300 million i..
2017Shenzhen Kangtai Biological Products Co., Ltd. Announces Final Cash Dividend for the Ye..
2017Shenzhen Kangtai Biological Products Co., Ltd. Announces Cash Dividend for 2016
2017Shenzhen Kangtai Biological Products Co., Ltd. Proposes Cash Dividend for the Year 2016
2017Beijing Minhai Biotechnology Co., Ltd. announced that it expects to receive CNY 300 mil..
2017Shenzhen Kangtai Biological Products Co., Ltd.(SZSE..
2017Shenzhen Kangtai Biological Products Co., Ltd.(SZSE..
2017Shenzhen Kangtai Biological Products Co., Ltd. has completed an IPO in the amount of CN..
2016Shenzhen Kangtai Biological Products Co., Ltd. has filed an IPO.
2016Shenzhen Kangtai Biological Products Co., Ltd. has withdrawn its IPO.
2012Shenzhen Kangtai Biological Products Co., Ltd. announced that it has received funding f..
Anstehende Termine für SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.